This study is in progress, not accepting new patients
Teplizumab in Pediatric Stage 2 Type 1 Diabetes
Summary
- Eligibility
- for people ages 0-7 (full criteria)
- Location
- at UCSF
- Dates
- study startedcompletion around
Description
Summary
Official Title
Details
Keywords
Eligibility
Locations
Details
- Status
- in progress, not accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Provention Bio, a Sanofi Company
- ID
- NCT05757713
- Phase
- Phase 4 research study
- Study Type
- Interventional
- Participants
- Expecting 20 study participants
- Last Updated